SEC Form 4 · accession 0001179110-16-021215
OSIRIS THERAPEUTICS, INC. · OSIR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Bobby Dwayne Montgomery
Officer — Chief Executive Officer · Director
Period of report
Mar 4, 2016
Accepted (ET)
Mar 7, 2016 · 8:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001360886
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $7.39 | Mar 4, 2016 | A | 10,000 | A | Mar 4, 2017 | Mar 4, 2025 | Common Stock | 10,000 | 47,500 | D |
Explanation of responses
- F1Options to purchase 10,000 shares of the common stock of the Registrant shall become exercisable with respect to the underlying shares as to 25% on each March 4, 2017, 2018, 2019, 2020, assuming the Reporting Person continues to be employed by the Registrant on the vesting date.